Liquid Biopsy: Differences Among Technologies

Sandip Patel, MD, and Geoffrey R. Oxnard, MD, discuss differences among platforms for genetic profiling of metastatic non–small cell lung cancer in terms of sensitivity, specificity, and multiplex capability, as well as detection of complex genomic alterations.

Leave a Reply

Your email address will not be published. Required fields are marked *